These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 2105528)

  • 41. Cloning of R kappa B, a novel DNA-binding protein that recognizes the interleukin-2 receptor alpha chain kappa B site.
    Adams BS; Leung KY; Hanley EW; Nabel GJ
    New Biol; 1991 Nov; 3(11):1063-73. PubMed ID: 1777480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunoglobulin synthesis in non-B cell lines.
    Hawley T; Hawley RG; Pauling J; Ochi A; Hozumi N
    Immunol Lett; 1986 Jun; 12(5-6):257-62. PubMed ID: 3089923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of E mu, 3'alpha (hs 1,2) and 3'kappa enhancers on mutation of an Ig-VDJ-Cgamma2a Ig heavy gene in cultured B cells.
    Lin MM; Green NS; Zhang W; Scharff MD
    Int Immunol; 1998 Aug; 10(8):1121-9. PubMed ID: 9723698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility.
    Lenardo M; Pierce JW; Baltimore D
    Science; 1987 Jun; 236(4808):1573-7. PubMed ID: 3109035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complex regulation of the immunoglobulin mu heavy-chain gene enhancer: microB, a new determinant of enhancer function.
    Nelsen B; Kadesch T; Sen R
    Mol Cell Biol; 1990 Jun; 10(6):3145-54. PubMed ID: 2111446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An enhancer associated with the mouse immunoglobulin lambda 1 gene is specific for lambda light chain producing cells.
    Bich-Thuy LT; Queen C
    Nucleic Acids Res; 1989 Jul; 17(13):5307-21. PubMed ID: 2503812
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An immunoglobulin mutator that targets G.C base pairs.
    Bachl J; Wabl M
    Proc Natl Acad Sci U S A; 1996 Jan; 93(2):851-5. PubMed ID: 8570647
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A system for precise analysis of transcription-regulating elements of immunoglobulin genes.
    Cheng EY; Collins C; Berru M; Shulman MJ
    BMC Biotechnol; 2005 Oct; 5():27. PubMed ID: 16202157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription.
    Shah PC; Bertolino E; Singh H
    EMBO J; 1997 Dec; 16(23):7105-17. PubMed ID: 9384588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The coupling between enhancer activity and hypomethylation of kappa immunoglobulin genes is developmentally regulated.
    Kelley DE; Pollok BA; Atchison ML; Perry RP
    Mol Cell Biol; 1988 Feb; 8(2):930-7. PubMed ID: 3127693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two conserved essential motifs of the murine immunoglobulin lambda enhancers bind B-cell-specific factors.
    Rudin CM; Storb U
    Mol Cell Biol; 1992 Jan; 12(1):309-20. PubMed ID: 1729607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro.
    Kawakami K; Scheidereit C; Roeder RG
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4700-4. PubMed ID: 3133660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclear factors bind to regulatory regions of the mouse kappa immunoglobulin gene.
    Hromas R; Van Ness B
    Nucleic Acids Res; 1986 Jun; 14(12):4837-48. PubMed ID: 3088544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Developmental regulation of the kappa locus involves both positive and negative sequence elements in the 3' enhancer that affect synergy with the intron enhancer.
    Liu X; Prabhu A; Van Ness B
    J Biol Chem; 1999 Feb; 274(6):3285-93. PubMed ID: 9920868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo occupancy of the kappa light chain enhancers in primary pro- and pre-B cells: a model for kappa locus activation.
    Shaffer AL; Peng A; Schlissel MS
    Immunity; 1997 Feb; 6(2):131-43. PubMed ID: 9047235
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of an octamer-binding site in the human kappa light-chain enhancer.
    Nelms K; Van Ness B
    Mol Cell Biol; 1990 Jul; 10(7):3843-6. PubMed ID: 2113179
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes.
    Cross SL; Halden NF; Lenardo MJ; Leonard WJ
    Science; 1989 Apr; 244(4903):466-9. PubMed ID: 2497520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of anti-IgM suppression on polyclonally activated murine B cells: analysis of immunoglobulin mRNA, gene specific nuclear factors and cell cycle distribution.
    Marcuzzi A; Van Ness B; Rouse T; Lafrenz D
    Nucleic Acids Res; 1989 Dec; 17(24):10455-72. PubMed ID: 2481271
    [TBL] [Abstract][Full Text] [Related]  

  • 59. B cell-specific demethylation: a novel role for the intronic kappa chain enhancer sequence.
    Lichtenstein M; Keini G; Cedar H; Bergman Y
    Cell; 1994 Mar; 76(5):913-23. PubMed ID: 8124725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Two related helix-loop-helix proteins participate in separate cell-specific complexes that bind the insulin enhancer.
    German MS; Blanar MA; Nelson C; Moss LG; Rutter WJ
    Mol Endocrinol; 1991 Feb; 5(2):292-9. PubMed ID: 1710033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.